| Dr Jayaram S Bharadwaj, MD | |
|
1801 W Romneya Dr Ste 203, Anaheim, CA 92801-1824 | |
| (714) 999-1465 | |
| (714) 999-1701 |
| Full Name | Dr Jayaram S Bharadwaj |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 33 Years |
| Location | 1801 W Romneya Dr Ste 203, Anaheim, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083602155 | NPI | - | NPPES |
| 715415 | Other | ND | MEDICARE |
| 10090 | Medicaid | ND | |
| 207308404 | Medicaid | MO | |
| P00730797 | Other | MO | RAILROAD MEDICARE |
| 177919001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 2002001982 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ahmc Anaheim Regional Medical Center | Anaheim, CA | Hospital |
| West Anaheim Medical Center | Anaheim, CA | Hospital |
| Placentia Linda Hospital | Placentia, CA | Hospital |
| St Jude Medical Center | Fullerton, CA | Hospital |
| Foothill Regional Medical Center | Tustin, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Los Angeles Hematology-oncology Medical Group | 6608819594 | 23 |
| Pacific Cancer Medical Center Inc | 4486547502 | 5 |
News Archive
Eye research charity Fight for Sight is raising awareness of the importance of eye donation and the current shortfall in corneas for transplant, after research found that eyes are the organ Brits would be the least likely to donate after their death, when asked to choose from a list.
A team of investigators, led by Dr. Benjamin F. Mann, from Merck, USA have published a new study on the preprint server bioRxiv*. They have used a biochemical approach to control the glycosylation profile of the S protein receptor-binding domain (RBD) and to analyze the effect of different glycosylation patterns on receptor binding.
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
I-FLOW CORPORATION announced today that total revenue for the third quarter ended September 30, 2009 increased 14% to $36.7 million compared to total revenue of $32.2 million for the third quarter of 2008.
Researchers from the University of Leicester and University Hospitals of Leicester NHS Trust have introduced an alternative method to diagnose the cause of death, which in many cases can replace the need for the traditional invasive autopsy. This can be purchased by the family and will be performed within the NHS hospitals.
› Verified 7 days ago
| Entity Name | Pacific Cancer Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336113489 PECOS PAC ID: 4486547502 Enrollment ID: O20040203001045 |
News Archive
Eye research charity Fight for Sight is raising awareness of the importance of eye donation and the current shortfall in corneas for transplant, after research found that eyes are the organ Brits would be the least likely to donate after their death, when asked to choose from a list.
A team of investigators, led by Dr. Benjamin F. Mann, from Merck, USA have published a new study on the preprint server bioRxiv*. They have used a biochemical approach to control the glycosylation profile of the S protein receptor-binding domain (RBD) and to analyze the effect of different glycosylation patterns on receptor binding.
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
I-FLOW CORPORATION announced today that total revenue for the third quarter ended September 30, 2009 increased 14% to $36.7 million compared to total revenue of $32.2 million for the third quarter of 2008.
Researchers from the University of Leicester and University Hospitals of Leicester NHS Trust have introduced an alternative method to diagnose the cause of death, which in many cases can replace the need for the traditional invasive autopsy. This can be purchased by the family and will be performed within the NHS hospitals.
› Verified 7 days ago
| Entity Name | Los Angeles Hematology-oncology Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457409674 PECOS PAC ID: 6608819594 Enrollment ID: O20050601001068 |
News Archive
Eye research charity Fight for Sight is raising awareness of the importance of eye donation and the current shortfall in corneas for transplant, after research found that eyes are the organ Brits would be the least likely to donate after their death, when asked to choose from a list.
A team of investigators, led by Dr. Benjamin F. Mann, from Merck, USA have published a new study on the preprint server bioRxiv*. They have used a biochemical approach to control the glycosylation profile of the S protein receptor-binding domain (RBD) and to analyze the effect of different glycosylation patterns on receptor binding.
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
I-FLOW CORPORATION announced today that total revenue for the third quarter ended September 30, 2009 increased 14% to $36.7 million compared to total revenue of $32.2 million for the third quarter of 2008.
Researchers from the University of Leicester and University Hospitals of Leicester NHS Trust have introduced an alternative method to diagnose the cause of death, which in many cases can replace the need for the traditional invasive autopsy. This can be purchased by the family and will be performed within the NHS hospitals.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jayaram S Bharadwaj, MD 1801 W Romneya Dr Ste 203, Anaheim, CA 92801-1824 Ph: (714) 999-1465 | Dr Jayaram S Bharadwaj, MD 1801 W Romneya Dr Ste 203, Anaheim, CA 92801-1824 Ph: (714) 999-1465 |
News Archive
Eye research charity Fight for Sight is raising awareness of the importance of eye donation and the current shortfall in corneas for transplant, after research found that eyes are the organ Brits would be the least likely to donate after their death, when asked to choose from a list.
A team of investigators, led by Dr. Benjamin F. Mann, from Merck, USA have published a new study on the preprint server bioRxiv*. They have used a biochemical approach to control the glycosylation profile of the S protein receptor-binding domain (RBD) and to analyze the effect of different glycosylation patterns on receptor binding.
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
I-FLOW CORPORATION announced today that total revenue for the third quarter ended September 30, 2009 increased 14% to $36.7 million compared to total revenue of $32.2 million for the third quarter of 2008.
Researchers from the University of Leicester and University Hospitals of Leicester NHS Trust have introduced an alternative method to diagnose the cause of death, which in many cases can replace the need for the traditional invasive autopsy. This can be purchased by the family and will be performed within the NHS hospitals.
› Verified 7 days ago
Richard Eugene Hughes, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1300 N. Kraemer Blvd., Anaheim, CA 92806 Phone: 714-630-6363 Fax: 714-630-1921 | |
Michael Salvaggio, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Kaiser Permanente-orange County, 411 N. Lakeview Ave, Anaheim, CA 92807 Phone: 714-279-4594 | |
Abraham Harn, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave Ste 404, Anaheim, CA 92801 Phone: 714-772-8282 Fax: 714-772-6493 | |
Aleem A Syed, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, Suite 702, Anaheim, CA 92801 Phone: 714-533-0300 Fax: 714-533-0700 | |
Dr. Jagminder Singh Bhalla, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1781 W Romneya Dr, Ste C, Anaheim, CA 92801 Phone: 714-956-3160 Fax: 714-956-1188 | |
Dr. Ashley E. Mires, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, #207, Anaheim, CA 92801 Phone: 714-772-8282 Fax: 714-772-6493 | |
Hyon Chong Seo, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |